2 studies on Ghs r1a mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**GHS-R1a agonists may represent a single-class intervention capable of addressing GH decline, metabolic liver aging, immune senescence, and dopaminergic deficits simultaneously** — a breadth no current approved thera…
The findings suggest that the ghrelin system's role in blood pressure and kidney function is significantly different in the context of pre-existing hypertension, which appears linked to a downregulation of `GHS-R1a` r…